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Summary
Wilson disease is an autosomal recessive disorder of cop-
per transport that causes hepatic and/or neurological
disease resulting from copper accumulation in the liver
and brain. The protein defective in this disorder is a
putative copper-transporting P-type ATPase, ATP7B.
More than 100 mutations have been identified in the
ATP7B gene of patients with Wilson disease. To deter-
mine the effect of Wilson disease missense mutations on
ATP7B function, we have developed a yeast comple-
mentation assay based on the ability of ATP7B to com-
plement the high-affinity iron-uptake deficiency of the
yeast mutant ccc2. We characterized missense mutations
found in the predicted membrane-spanning segments of
ATP7B. Ten mutations have been made in the ATP7B
cDNA by site-directed mutagenesis: five Wilson disease
missense mutations, two mutations originally classified
as possible disease-causing mutations, two putative
ATP7B normal variants, and mutation of the cysteine-
proline-cysteine (CPC) motif conserved in heavy-
metal–transporting P-type ATPases. All seven putative
Wilson disease mutants tested were able to at least par-
tially complement ccc2 mutant yeast, indicating that
they retain some ability to transport copper. One mu-
tation was a temperature-sensitive mutation that was
able to complement ccc2 mutant yeast at 30C but was
unable to complement at 37C. Mutation of the CPC
motif resulted in a nonfunctional protein, which dem-
onstrates that this motif is essential for copper transport
by ATP7B. Of the two putative ATP7B normal variants
tested, one resulted in a nonfunctional protein, which
suggests that it is a disease-causing mutation.
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Introduction
Integral membrane P-type ATPases have been shown to
be important for heavy-metal homeostasis in eukaryotes
and prokaryotes (Brown et al. 1992; Silver 1992; Bull
and Cox 1994; Solioz 1998). Prokaryotic heavy-metal–
transporting P-type ATPases are thought to have evolved
as a defense against toxic metals in the environment. In
eukaryotes, copper-transporting P-type ATPases are in-
volved in copper and iron homeostasis. Defective copper
transporters are responsible for human Menkes disease
and Wilson disease.
Wilson disease is an autosomal recessive disorder of
copper transport mapped to 13q14.3 (Farrer et al.
1991). The disease has a worldwide frequency of ∼1/
35,000, is characterized by chronic liver and/or neuro-
logical disease, and is often accompanied by kidney mal-
function (Cox and Roberts 1998). Symptoms are caused
by deposition of copper in the liver, brain, and kidneys
as a result of severely impaired hepatic biliary excretion
of copper. It is unclear whether deposition of copper in
the brain and kidneys is specific or secondary to hepatic
copper overload (Danks 1995). Incorporation of copper
into ceruloplasmin is impaired, although Wilson disease
patients may have normal levels of serum ceruloplasmin.
The Wilson disease gene (ATP7B) has been cloned and
is predicted to encode a copper-transporting P-type ATP-
ase with a molecular mass of 159 kD (Bull et al. 1993;
Tanzi et al. 1993). On the basis of northern blots,ATP7B
has been found to be expressed at high levels in the liver
and kidneys and at low levels in the brain. Experiments
with rats and in hepatic cell cultures have shown that
ATP7B is required for biliary copper excretion via the
lysosomes and for incorporation of copper into ceru-
loplasmin within the secretory pathway (Gross et al.
1989; Schilsky et al. 1994; Murata et al. 1995). ATP7B
has been localized to the trans-Golgi network (TGN) of
hepatocytes and has been shown to undergo copper-
dependent trafficking to an undefined vesicular com-
partment (Hung et al. 1997). One study suggests that
ATP7B may also be localized to the mitochondria (Lut-
senko and Cooper 1998). ATP7B shares a high degree
of similarity with the copper-transporting P-type ATPase
defective in Menkes disease (ATP7A; Bull et al. 1993),
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Figure 1 Model of yeast copper and iron homeostasis. The
plasma membrane protein Ctr1p transports copper with high affinity
into the cytoplasm (Dancis et al. 1994). Copper is carried in the cy-
toplasm by the copper chaperone Atx1p (Lin et al. 1997), which de-
livers copper to Ccc2p. Copper is supplied by Ccc2p, within a post-
Golgi compartment (Yuan et al. 1997), to the plasma membrane
oxidase Fet3p, which functions with the high-affinity iron transporter
Ftr1p to import iron (Stearman et al. 1996). When yeast cells lack
Ccc2p, copper is not incorporated into Fet3p, and subsequently the
cells lack high-affinity iron uptake (Yuan et al. 1995). In the absence
of high-affinity iron uptake, ccc2 mutant yeast cells are unable to grow
on iron-limited medium. This diagram has been adapted from recent
publications (Stearman et al. 1996; Lin et al. 1997).
which undergoes a copper-dependent trafficking event
from the trans-Golgi to the plasma membrane of Chinese
hamster ovary cells (Petris et al. 1996).
More than 100 mutations have been found in the
ATP7B gene of Wilson disease patients (Krawczak et al.
1997). Nonsense, frameshift, and splice-site mutation-
shave been found throughout the gene. Missense mu-
tations, however, tend to be clustered within the putative
ATP-binding domain and the membrane-spanning seg-
ments, which supports the importance of these structures
for the proposed ATP-dependent copper transport func-
tion of ATP7B. No disease-associated missense muta-
tions have been found in the metal-binding motifs of
ATP7B (or ATP7A), perhaps because of functional re-
dundancy among the six repeated motifs. A base-pair
substitution generally is considered to be disease causing
if it is not found on 50 normal chromosomes from the
same population, if no other mutations can be detected,
if the amino acid substitution is nonconservative, or if
the substituted amino acid is conserved in functionally
related proteins (e.g., ATP7A). There may be difficulty
in distinguishing disease-causing missense mutations
from rare normal variants not yet found on normal chro-
mosomes, especially when the amino acid change ap-
pears to be conservative. Therefore, it is desirable to have
a functional means to distinguish disease mutations from
normal variants.
Wilson disease symptoms are highly variable, even in
patients homozygous for the common northern Euro-
pean mutation histidine1069glutamine (H1069Q; D.
W.C., unpublished data). Environmental effects such as
dietary copper intake may be a factor. Genetic back-
ground may also affect disease severity. For example,
among patients, allelic differences in metallothionien
and superoxide dismutase genes could alter the ability
of tissues to cope with copper overload. Most Wilson
disease mutations occur at low frequency; therefore,
most patients are compound heterozygotes. These fac-
tors combine to make genotype/phenotype correlations
difficult. The ability to determine the degree to which a
missense mutation affects protein function may be help-
ful for the interpretation of the phenotype of patients
and may give insight into the biochemical basis of disease
variability.
The yeast (Saccharomyces cerevisiae) homologue of
ATP7B is CCC2 (Yuan et al. 1995). In yeast, the protein
product, Ccc2p, is part of the pathway required for high-
affinity iron uptake (fig. 1). We have developed a func-
tional assay for ATP7B, on the basis of the complemen-
tation of the yeast mutant ccc2. Expression of ATP7B
in ccc2 mutant cells complements the mutation and re-
stores the cells’ ability to grow on iron-limited medium.
Similiar functional assays recently have been reported
and used to study ATP7A (Payne and Gitlin 1998),
ATP7B (Hung et al. 1997; Iida et al. 1998), and CUA-
1, the Caenorhabditis elegans homologue of ATP7A/
ATP7B (Sambongi et al. 1997; Yoshimizu et al. 1998).
We are using complementation of the high-affinity iron-
uptake–deficiency phenotype of the ccc2 mutant yeast
as an indirect assay to test the degree to which Wilson
disease mutations found in the membrane-spanning seg-
ments of ATP7B affect protein function.
Material and Methods
Yeast Strains
The wild-type strain used in all experiments was the
protease-deficient S. cerevisiae strain BJ2168 (MATa-
pep4–3 prcl–407 prb1–1122 ura3–52 trp1 leu2; Zu-
benko et al. 1980). This strain was chosen to minimize
potential proteolysis during procedures such as the
oxidase assay in which samples are not heated prior to
electrophoresis. Yeast mutants fet3 and ccc2, which lack
functional FET3 and CCC2 genes, were made by the
transformation of BJ2168 with the linearized plasmids
pDfet3 and E5-URA3.4 (plasmid described by Yuan et
al. 1995), respectively. Integrations were selected on syn-
thetic dextrose (SD) medium lacking uracil. Transfor-
mants were plated on nonfermentable glycerol carbon-
source medium either unsupplemented or supplemented
with 500 mM copper sulfate or 1 mM ferrous ammonium
sulfate, to confirm the metal-dependent respiration-de-
ficiency phenotype of the mutant strains as described by
Yuan et al. (1995). All transformations were performed
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by use of a modified lithium acetate method (Elble
1992).
Construction of ATP7B cDNA and Mutagenesis
Total human liver RNA was used for reverse tran-
scription (RT) using random hexamer primers and mo-
lony murine leukemia–virus reverse transcriptase, in ac-
cordance with the protocol of the manufacturer
(Pharmacia). cDNA obtained by this method was used
as a template for PCR amplification of five overlapping
fragments that contained the coding region of ATP7B,
by use of pfu polymerase in the buffer supplied by the
manufacturer (Stratagene). Primers were chosen in such
a way that unique restriction sites were present at the
ends of each fragment, which facilitated the construction
of the full-length cDNA. A 5′ BamHI site was added to
the PCR primer sequence immediately preceding the in-
itiating ATG codon. PCR fragments were A-tailed by
incubation with Taq polymerase. A-tailed PCR frag-
ments were cloned by use of T/A-cloning vectors (Pro-
mega, Invitrogen). The two most 5′ cDNA fragments
encoding the copper-binding domain proved to be un-
stable when transformed into bacteria, which resulted
in plasmid mutation and rearrangements. This was cor-
rected by the addition of 100 mM CuSO4 to the culture
medium. Each fragment was sequenced (Sequenase,
Amersham) to ensure that no sequence errors were pres-
ent, and the full-length cDNA was constructed by li-
gating the fragments together. The final cDNA construct
was cloned into pUC19 by use of the 5′ BamHI site and
a 3′ SalI site from the polylinker of the Promega T/A
vector.
To create mutations in the ATP7B cDNA, oligonu-
cleotides carrying the desired codon changes were syn-
thesized. Mutant cDNAs were made by use of the
QuickChange method (Stratagene). The fragments were
sequenced to ensure that there were no secondary mu-
tations and then were ligated back into an unmanipu-
lated cDNA, to create the mutant constructs.
Expression Vectors
For high-level expression of ATP7B in yeast, cDNAs
were cloned into the multicopy 2m replication-origin vec-
tor pG3 (Schena et al. 1991). This vector utilizes a
constitutive glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) promoter, a phosphoglycerate kinase (PGK)
terminator and polyadenylation sequence, and a tryp-
tophan-selectable marker. A single-copy integrating vec-
tor named “pG4” was derived from pG3. The pG3 2m
replication origin, carried on a single EcoRI fragment,
was removed by use of restriction-enzyme digestion. The
vector lacking its yeast origin of replication was agarose-
gel purified (Qiagen) and ligated to form pG4. Expres-
sion vectors were transformed into yeast, and transfor-
mants were selected on SD medium lacking tryptophan.
Genomic DNA isolated from yeast strains that carried
pG4 constructs were analyzed by use of Southern blot
analysis, to confirm that the constructs were correctly
integrated as single copy.
Complementation Assay
The assay medium consisted of SD medium made with
a yeast nitrogen base lacking iron and copper (Bio-101),
supplemented with all amino acids, except tryptophan,
and 50 mM MES buffer, pH 6.1. The iron-limited me-
dium was SD medium with 1 mM ferrozine (an iron-
specific chelator), 50 mM ferrous ammonium sulfate, and
1 mM copper sulfate. The iron-limited medium was sup-
plemented to 500 mM copper sulfate or 350 mM ferrous
ammonium sulfate, to make the copper- or iron-suffi-
cient control media, respectively. For the plating assay,
the medium contained 2% Bacto agar (Difco). Cells were
prepared for growth-curve analysis and plating assays
in the following manner: stationary yeast cultures grown
in SD liquid culture were washed with ice-cold distilled
water, resuspended in iron-limited medium, and then
grown to saturation overnight. For the plating assay,
these cultures were diluted to an optical density of
in 1 ml sterile deionized water; 5 ml of thisOD  0.1600
cell suspension was streaked onto plates containing the
assay media. Cells were grown at 30C or at 37C and
were photographed after 48 h. To measure the growth
curves of yeast strains, saturated yeast cultures grown
in the iron-limited medium were pelleted and resus-
pended in fresh iron-limited medium. This was used to
inoculate cultures at a density of . CulturesOD  0.1600
were grown at 30C for 24 h while growth was moni-
tored spectroscopically after 0, 3, 6, 12, and 24 h.
Oxidase Assay
Fet3p oxidase activity was measured by use of a mod-
ified version of the assay described by Yuan et al. (1995).
Cells were grown to mid–log phase (at 30C) in SD me-
dia lacking tryptophan, iron, and copper and supple-
mented with 50 mM MES buffer, pH 6.1, and 0.5 mM
copper sulfate. The buffer for homogenization consisted
of 25 mM HEPES-NaOH, pH 7.4, 150 mM NaCl; and
a protease-inhibitor cocktail of 30 mM leupeptin, 10 mM
pepstatin A, and 5 mM aprotinin. The buffer was sup-
plemented during homogenization, with either 1 mM
bathocuproinedisulfonate (BCS, a copper chelator) and
1 mM ascorbate, to prevent copper-loading of Fet3p
during homogenization, or with 50 mM CuSO4, to re-
constitute apo-Fet3p (Fet3p lacking bound copper) in
vitro during homogenization, as a positive control. Cells
from 25 ml of culture were washed twice with ice-cold
distilled water and once with 800 ml supplemented buffer
and then were resuspended in 200 ml of the same. Cells
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were broken by vortexing with glass beads for 5 min.
Yeast membranes were recovered by the addition of 800
ml buffer supplemented as above, and the supernatants
were cleared of unbroken cells and heavy organelles by
centrifugation at 10,000 g for 30 s. This step was re-
peated once. Membranes were collected by centrifuga-
tion at 20,000 g for 30 min, and then were washed with
buffer containing 1 mM BCS. The final membrane pellet
was solubilized in 100 ml buffer that contained 1mM
BCS and 1% Triton X-100. Insoluble material was re-
moved by centrifugation at 20,000 g. Protein was quan-
tified by use of the Enhanced Bradford assay (Pierce
Chemical). Solubilized membrane proteins (30 mg) were
dissolved in Laemmli loading buffer (Laemmli 1970)
lacking DTT and were run on 7.5% SDS-PAGE gels,
without prior heating. Gels were equilibrated for 1 h in
20 gel volumes of oxidase buffer containing 100 mM
sodium acetate, pH 5.7, 10% glycerol, 1 mM sodium
azide, and 0.05% Triton X-100. Equilibrated gels were
soaked in buffer containing 100 mM sodium acetate,
pH 5.7, 0.5 mg/ml p-phenylenediamine dihydrochloride
substrate, and 1 mM sodium azide, for 1 h in the dark.
Gels were incubated overnight in the dark between cel-
lophane sheets in a humidified box to develop bands of
oxidase activity. All glassware was washed with hy-
drochloric acid and well rinsed with deionized water, to
eliminate copper contamination.
Polyclonal Antibody against ATP7B
A histidine-tagged fusion protein corresponding to the
C-terminal fragment of ATP7B (amino acids 1375–
1465) was expressed inEscherichia coli. The protein was
very insoluble and was purified by nickel-affinity chro-
matography under denaturing conditions in phosphate-
buffered saline (PBS) that contained 8 M urea. Protein
bound to the affinity columns was washed with buffer
solution containing increasing concentrations of imid-
azole, and the fusion protein was eluted with 100 mM
imidazole. Purified protein was judged to be 195% pure
by SDS-PAGE analysis. Purified protein was dialyzed
against several changes of PBS, to remove the urea. The
insoluble precipitate was lyophilized. Lyophilized pro-
tein was resuspended, conjugated to keyhole limpet he-
mocyanin (KLH), and injected into rabbits, by Dr. Greg-
ory Lee at the University of British Columbia. The
antiserum obtained was affinity purified by running 250
mg fusion protein on 15% SDS-PAGE gels. Protein was
electrophoretically transferred to polyvinylidene difluor-
ide (PVDF) membrane, and the antigen band was cut
out. Several antigen strips were blocked with 3% BSA
in PBS containing 0.1% Tween-20 (PBST), were incu-
bated at 4C with 500 ml rabbit antiserum diluted in
PBST, and then were washed. Bound antibody was
eluted with 50 mM glycine, pH 2.7. The eluate was
neutralized with Tris buffer and was concentrated by use
of a centricon-30 (Amicon) ultrafiltration device. The
final antibody, designated “anti-ATP7B.C10,” was made
to l# PBS and 0.1% BSA, for storage at 20C.
Protein Preparations and Western Blotting
Homogenization buffer consisted of 25 mM HEPES-
NaOH, pH 7.4; 150 mM NaC1; 1 mM DTT; and a
protease-inhibitor cocktail that contained 30 mM leu-
peptin, 10 mM pepstatin A, 5 mM aprotinin, and 1 mM
EDTA. Cells from 10 ml stationary culture were washed
twice with ice-cold distilled water, and once with ho-
mogenization buffer, and were resuspended in 200 ml
buffer. Cells were broken by vortexing in the presence
of glass beads for 5 min. The homogenate was centri-
fuged for 30 s at 10,000 g to remove unbroken cells and
heavy organelles. Protein content was estimated by use
of the Enhanced Bradford assay (Pierce Chemical). Pro-
tein was mixed with Laemmli loading buffer (Laemmli
1970) that contained DTT and was heated for 5 min at
75C. SDS-PAGE was performed by use of 7.5% poly-
acrylamide gels. Protein was transferred electrophoret-
ically to PVDF membrane for 450 V-h in Towbin buffer
(Towbin et al. 1979) that contained 15% methanol and
0.01% SDS. Western blotting was performed by use of
anti-ATP7B.C10 as the primary antibody, at a 1/3,000
dilution. The secondary antibody was horseradish per-
oxidase–conjugated goat antirabbit antibody, at a di-
lution of 1/10,000 (Pierce Chemical). Bound antibody
was detected by enhanced chemiluminescense using Su-
persignal substrate (Pierce Chemical).
Results
Construction of ATP7B cDNA
ATP7B cDNA was constructed by the ligation of five
overlapping fragments generated by RT-PCR. The two
fragments that encode the copper-binding domain
proved to be unstable and prone to frequent deletion
and mutation when grown in E. coli. We hypothesized
that expression of these fragments during growth could
produce a polypeptide capable of binding copper, which
would result in copper depletion within bacterial cells
in such a way that only cells harboring deleted or mu-
tated cDNAs were capable of growth. These clones were
stabilized by supplementing the growth medium with
copper. The full-length cDNA was ligated into pUC19
vector, with the coding region in reverse orientation to
the vector’s lacZ promoter. ATP7B cDNA cloned in this
manner was stable in E. coli without added copper.
Antibody against ATP7B
A rabbit polyclonal antiserum was prepared against
a histidine-tagged fusion protein containing the 10-kD
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Figure 2 Expression of ATP7B in yeast. ATP7B was expressed
in ccc2 mutant yeast and analyzed by western blotting. Analysis of 40
mg total yeast protein was performed by enhanced chemiluminescense
using an affinity-purified rabbit polyclonal antibody against the C-
terminal 10-kD fragment of ATP7B (anti-ATP7B.C10). Lanes 1 and
2, Yeast protein from strains that harbored an empty expression vector
only. Lanes 3 and 4, Yeast protein from strains that harbored the single-
copy or multicopy ATP7B expression constructs, respectively. ATP7B
migrated as a doublet of ∼163 and ∼177 kD. The multicopy vector
(pG3) produced ∼30-fold more ATP7B protein than did the single-
copy vector (pG4), as estimated by densitometry (data not shown).
C-terminal fragment (residues 1375–1465) of ATP7B.
The fusion protein, poorly antigenic in rabbits, was con-
jugated to KLH as a carrier protein and was used in this
form to produce a polyclonal antiserum. The antiserum
obtained recognized the fusion protein on western blots,
whereas the preimmune serum did not (data not shown).
The antiserum, designated “anti-ATP7B.C10,” was af-
finity purified to reduce nonspecific signals on western
blots.
Expression of ATP7B in Yeast
To express ATP7B in yeast, the cDNA was cloned
into two expression vectors: a multicopy vector (pG3)
and a single-copy integrating vector (pG4). These vectors
were used so that the level of ATP7B expression could
be controlled by plasmid copy number. ATP7B expres-
sion in yeast protein extracts was analyzed by western
blotting using anti-ATP7B.C10 (fig. 2). ATP7B protein
produced in yeast migrated as a doublet of ∼163 and
∼177 kD. The 163-kD band was the predominant prod-
uct, since the larger band was not detected when pro-
duced at lower levels from the single-copy vector. The
molecular weight of the 163-kD band agrees well with
the predicted molecular weight of 159 kD for ATP7B
and with the molecular weights determined previously
by other groups (Hung et al. 1997; Iida et al. 1998;
Lutsenko and Cooper 1998). The larger protein band
probably represents a glycosylated form of ATP7B pro-
duced in yeast. ATP7B was found entirely in yeast
membrane pellets, which is consistent with its predicted
integral membrane structure (data not shown).
Functional Replacement of Ccc2p by ATP7B In Vivo
To test the function of normal and mutant ATP7B
proteins, we exploited the high-affinity iron-uptake de-
ficiency of the yeast mutant ccc2. In the absence of high-
affinity iron uptake, ccc2 mutant yeast harboring empty
expression vectors were unable to grow on iron-limited
medium (fig. 3A). Both single-copy and multicopy ex-
pression of ATP7B were able to complement the ccc2
mutation, which allowed the cells to grow. Growth res-
cue of ccc2 mutant yeast can be accomplished by the
addition of high concentrations of copper or iron to the
iron-limited growth medium (Yuan et al. 1995; Stear-
man et al. 1996). Under these conditions, iron enters the
cells by low-affinity pathways, or copper binds to apo-
Fet3p at the cell surface, which reconstitutes its activity
and restores high-affinity iron uptake. All yeast strains
tested were able to grow on culture plates that contained
copper- or iron-sufficient media, demonstrating that the
ccc2 mutant strains that contain empty vectors were vi-
able. Expression of ATP7B had no phenotypic effect on
fet3 or ctr1 mutant yeast strains (data not shown).
Fet3p oxidase activity, which is dependent on the cop-
per delivered to it by Ccc2p, serves as a marker enzyme
for the putative copper-transporting function of Ccc2p
(Yuan et al. 1995). Gel-based Fet3p oxidase assays were
used to provide biochemical evidence that ATP7B can
functionally replace Ccc2p in vivo. Fet3p activity was
absent in BCS/ascorbate protein extracts from the ccc2
mutant yeast–harboring vector only (fig. 3B). BCS and
ascorbate were included in the homogenization buffer,
to prevent adventitous copper incorporation into Fet3p,
so that only holo-Fet3p (Fet3p with copper bound), cop-
per loaded in vivo during biosynthesis, was detected.
Expression of ATP7B in ccc2mutant yeast restored holo-
Fet3p activity in vivo. As a positive control, Fet3p assays
were performed on protein extracts from yeast homog-
enized in the presence of copper. Copper is able to re-
constitute apo-Fet3p in vitro, restoring its oxidase ac-
tivity such that total cellular Fet3p activity is detected
(Yuan et al. 1995). Although Fet3p activity was absent
in the ccc2 strain, apo-Fet3p was still produced and was
capable of functioning when reconstituted with copper
(fig. 3B). Reconstituted total-Fet3p activity was consid-
erably higher in the ccc2 strain than in wild-type or
ATP7B-complemented strains. In ccc2 mutant cells, cop-
per is not incorporated into Fet3p, and, therefore,
high-affinity iron uptake is abolished (Yuan et al.1995).
In the absence of high-affinity iron uptake, FET3 ex-
pression is induced to high levels (Askwith et al. 1994),
resulting in the accumulation of apo-Fet3p, which was
detected by copper reconstitution in vitro. These data
show that ATP7B was able to functionally replace
Ccc2p. ATP7B provided the putative copper transport
activity required to deliver copper to Fet3p and thereby
restored the ability of ccc2 mutant yeast to grow on iron-
limited medium.
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Figure 3 Complementation of ccc2 mutant yeast by ATP7B. A, Plating assay. B, Fet3p oxidase assay. Oxidase activity in the BCS/ascorbate
buffer represents holo-Fet3p copper loaded in vivo during biosynthesis. Oxidase activity in the copper buffer represents total-Fet3p activity
reconstituted in vitro during homogenization.
Complementation of ccc2 Mutant Yeast with ATP7B
Mutants
Site-directed mutagenesis was used to create muta-
tions in the ATP7B cDNA that correspond to those
found in the putative transmembrane segments of
ATP7B from Wilson disease patients. Five proposed dis-
ease-causing mutations were made: aspartate765-
asparagine (D765N), arginine778leucine (R778L), argi-
nine778glutamine (R778Q), glycine943serine (G943S),
and proline992leucine (P992L). Two mutations, methi-
onine769valine (M769V) and leucine776valine (L776-
V), originally designated as possible mutations because
of the conservative nature of the mutations, were made,
as well as two proposed normal variants, threo-
nine977methionine (T977M) and valine995alanine
(V995A) (Thomas et al. 1995). The cysteines of the cys-
teine-proline-cysteine (CPC) motif in transmembrane
segment six were mutated to serine (mutant construct
designated “CPC/S”). These mutant ATP7B proteins
were expressed in ccc2 mutant yeast from the single-
copy expression vector. The genomic DNA of all recom-
binant strains was checked by Southern blotting, to en-
sure single-copy integration of the expression constructs.
Complementation of ccc2 mutant yeast with these con-
structs is shown in figures 4A and 5A. Mutant proteins
D756N, M769V, L776V, G943S, and V995A appeared
to fully complement ccc2mutants, as did normal ATP7B.
Mutations R778L and P992L weakly rescued ccc2 mu-
tant yeast, and R778Q partially rescued the mutant
yeast. As expected, mutation of the CPC motif abrogated
function of ATP7B. The proposed normal variant
T977M was the only Wilson disease mutation tested that
resulted in a protein completely unable to complement
ccc2 mutant yeast.
These results were supported by the Fet3p oxidase-
assay data (figs. 4B and 5B). When the oxidase assay
results were interpreted, the ratio of holo-Fet3p activity
to total-Fet3p activity was informative. Wild-type yeast
and ATP7B-complemented ccc2 mutant yeast had sim-
ilar amounts of holo-Fet3p and total-Fet3p activity,
which indicates that there was little apo-Fet3p present.
However, yeast that expressed R778L, R778Q, and
P992L mutant ATP7B proteins exhibited reduced holo-
Fet3p activity but greatly increased total-Fet3p activity,
which indicates the presence of large amounts of apo-
Fet3p. This implies that ATP7B mutants with reduced
function could not deliver enough copper to Fet3p dur-
ing its biosynthesis in vivo, which led to an accumulation
of the apo-enzyme form. Therefore, the greater the
amount of total-Fet3p activity, in comparison with holo-
Fet3p activity, the greater the defect in mutant ATP7B
function. For example, R778L had a higher ratio of to-
tal-Fet3p to holo-Fet3p activity than did R778Q, which
indicates that the R778L mutation affected ATP7B func-
tion more severely. Oxidase-assay results were repro-
duced in several experiments.
Growth curves of yeast grown in iron-limited medium
were used to quantify the relative ability of Wilson dis-
ease mutant proteins, expressed from single-copy con-
structs, to complement ccc2 mutant yeast (table 1 and
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Figure 4 Complementation of ccc2 mutant yeast by ATP7B mutant proteins. A, Plating assay. Disease-mutation constructs were expressed
in the ccc2 mutant background and are designated in the legend by mutation. Wild-type (wt), Fet3, and ccc2 mutant strains harbor empty
expression vectors. B, Fet3p oxidase assay. Oxidase activity in the BCS/ascorbate buffer represents holo-Fet3p copper loaded in vivo during
biosynthesis. Oxidase activity in the copper buffer represents total-Fet3p activity reconstituted in vitro during homogenization.
fig. 6). The growth-rate data agreed well with the Fet3p
oxidase-assay results, which indicates that growth was
dependent on the ability of mutant ATP7B proteins to
incorporate copper into Fet3p in vivo.
Since all of the proposed Wilson disease mutations
were able to at least partially complement ccc2 mutant
yeast in single copy, cells were subjected to the further
stress of heat shock at 37C (table 1). Mutations R778L,
R778Q, and P992L, which were already affected at
30C, showed a more severe phenotype when grown on
iron-limited medium at 37C. R778L and P992L were
unable to complement ccc2 mutant yeast, whereas
R778Q did so very weakly. The only mutant profoundly
affected by heat stress was M769V, which was unable
to complement ccc2 mutant yeast at 37C. All other
mutants tested were unaffected by heat stress. When ov-
erexpressed from the multicopy vector, all mutations
tested, with the exception of T977M and CPC/S, were
able to fully complement ccc2 mutant yeast at both 30C
and 37C (data not shown).
Discussion
We have demonstrated that the human protein ATP7B
is able to replace functionally the yeast protein Ccc2p.
ATP7B provided the putative copper-transporting activ-
ity required for delivery of copper to Fet3p, thereby re-
storing its activity and correcting the high-affinity iron-
uptake–deficiency phenotype of the yeast ccc2 mutant
strain. We were able to quantify differences in the ability
of these proteins to complement ccc2 mutant yeast by
using growth rates of yeast that expressed ATP7B mu-
tant proteins, which agreed well with the degree to which
they were able to incorporate copper into Fet3p.
The Wilson disease mutations that we analyzed are
found within the transmembrane segments of ATP7B.
These regions of ATP7B harbor a large proportion of
Wilson disease–causing missense mutations, which un-
derscores their importance for the structure and function
of this protein. On the basis of extensive biochemical
work done on the related sarcoplasmic reticulum cal-
cium-transporting P-type ATPase (MacLennan et al.
1992), the transmembrane segments of ATP7B are likely
involved in the binding of copper, perhaps via the con-
served CPC motif, prior to its translocation across the
membrane bilayer. In addition to providing the topo-
logical framework for proper protein folding, the trans-
membrane segments of P-type ATPase undergo confor-
mational changes during cation transport that result in
the delivery of cations across membranes. Mutations in
the transmembrane segments that affect any of these
potential functions would be deleterious to ATP7B
function.
We have analyzed five mutations classified as Wilson
disease mutations, D765N, R778L, R778Q, G943S, and
P992L. D765N, a rare mutation found in patients of
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Figure 5 Complementation of ccc2 mutant yeast by ATP7B mutant proteins. A, Plating assay. Disease-mutation constructs were expressed
in the ccc2 mutant background and are designated in the legend by mutation. Wild-type (wt), Fet3, and ccc2 mutant strains harbor empty
expression vectors. B, Fet3p oxidase assay. Oxidase activity in the BCS/ascorbate buffer represents holo-Fet3p copper loaded in vivo during
biosynthesis. Oxidase activity in the copper buffer represents total-Fet3p activity reconstituted in vitro during homogenization.
Italian descent (Figus et al. 1995), fully complemented
the ccc2 mutant yeast at both 30C and at 37C, which
indicates normal copper-transport function in this assay.
This mutation may be a rare normal variant not yet
detected on normal chromosomes. Alternatively, D756N
could result in a mutant protein that has normal copper
transport activity but is incorrectly localized in
hepatocytes.
The Wilson disease mutation R778L is a common
mutation in patients of Asian descent (Thomas et al.
1995; Chuang et al. 1996; Nanji et al. 1997), repre-
senting 27% of alleles found in this population. In
homozygous form, this mutation is associated with the
early onset of Wilson disease with hepatic presentation
(D.W.C., unpublished data). This correlates well with
our functional data. R778L in single copy was able to
complement ccc2 mutant yeast at only 36.1% of that of
ccc2 mutant yeast expressing normal ATP7B, and it
could not complement ccc2 mutant yeast at 37C. This
mutation had severe effects on the function of ATP7B,
which confirmed its prediction as a disease-causing mu-
tation. It is interesting to note that the mutation R778Q,
found in Taiwanese patients (Chuang et al. 1996), had
a less severe effect on ATP7B function than R778L,
which is consistent with the fact that glutamine is more
closely related to arginine than is leucine. R778Q was
able to complement ccc2 mutant yeast in single copy at
51% of ATP7B-expressing yeast, and at 37C it com-
plemented ccc2 mutant yeast very weakly. Homozygous
R778Q mutation might be predicted to result in a milder
form of Wilson disease than is seen for R778L. Other
reported variants of this residue are R778G and R778W
(Chuang et al. 1996), for which there are no functional
data.
Mutation G943S was found in the Bangladeshi pop-
ulation and resulted in neurologic disease with onset in
late childhood, in a homozygous patient (Thomas et al.
1995). Complementation was slightly impaired (86%)
when expressed in single copy, compared with normal
ATP7B. P992L was found in a Japanese family (Nanji
et al. 1997). This change is found in a residue that is
highly conserved in copper-transporting P-type ATPases.
P992L in single copy had a severely impaired ability to
complement ccc2 mutant yeast, compared with normal
(29.1%) at 30C, and was completely impaired at 37C,
which supports its identity as a Wilson disease–causing
mutation.
Two mutations tested, M769V and L776V, originally
were not classified with certainty as disease-causing mu-
tations or as normal variants (Thomas et al. 1995).
These amino acid changes had been found to be the only
mutation on a few Wilson disease chromosomes and are
relatively conservative changes. However, these muta-
tions have not been found on normal chromosomes, and
the mutated residues are conserved in the Menkes disease
protein. When analyzed by complementation, M769V
expressed in single copy complemented ccc2 mutant
yeast to a level equivalent to normal ATP7B at 30C.
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Table 1
Growth Rates of ccc2 Mutant Yeast Strains Expressing Mutant ATP7B Proteins
Strain Original designation Growth rate
(DOD600/h)
Heat sensitive Functional designation
Wild-type ) .1146.0025 No )
fet3 ) .0210.0014a No )
ccc2 ) .0226.0020a No )
ATP7B ) .1140.0012 No )
CPC/S ) .0155.0008a No )
D765N Mutation .1110.0020 No Normal variant or mislocalized
R778L Mutation .0411.0016a,b Yes Mutation
R778Q Mutation .0581.0017a Yes Mutation
G943S Mutation .1001.0037a No Mutation
P992L Mutation .0330.0039a,b Yes Mutation
M769V Possible mutation .1094.0011 Yes Mutation
L776V Possible mutation .1131.0013 No Normal variant or mislocalized
T977M Possible normal variant .0220.0024a No Mutation
V995A Possible normal variant .1109.0037 No Normal variant
NOTE.—Growth rates in iron-limited medium of yeast expressing normal and mutant ATP7B variants at
30C. Growth curves were generated over a 24-h period. Rates were calculated from the linear exponential
growth phase between 3 and 12 h after inoculation. Average rates were calculated from four independent
experiments.
a Statistically significant difference from ATP7B (t-test, ).P 1 .001
b Statistically significant difference from R778Q (t-test, ).P 1 .001
However, M769V was a temperature-sensitive mutation
unable to complement at 37C. Since 37C is the tem-
perature at which ATP7B functions in the human cell,
M769V should be considered a disease-causing mutation
in patients. L776V was able to fully complement the
ccc2 mutant yeast strain expressed from a single copy
and was not affected by heat stress. This mutation may
be a rare normal variant not yet identified on normal
chromosomes or a mutation that affects the intracellular
localization of ATP7B, thereby impairing cellular copper
efflux.
We have tested two mutations originally predicted to
be normal variants. T977M and V995A are relatively
conservative amino acid changes that were found on
Wilson disease chromosomes for which a first mutation
was already identified, which led to their classification
as normal variants (Thomas et al. 1995). However, Wal-
denstrom et al. (1996) reported that T977M was the
only mutation found on seven Wilson disease chromo-
somes from patients of northern European descent, but
no normal chromosomes were tested. By use of our as-
say, T977M was found to be completely unable to com-
plement ccc2 mutant yeast, even when overexpressed.
These results demonstrate that this mutation resulted in
a nonfunctional protein and should be considered a Wil-
son disease–causing mutation in patients. V995A had
normal function in our assay, which is consistent with
its classification as a normal variant.
The CPC motif is evolutionarily conserved in heavy-
metal transporters (Bull and Cox 1994; Solioz and Vulpe
1996; Solioz 1998) and is predicted to be involved in
copper binding within the transmembrane domain of
these proteins during transport. The first cysteine and
proline of the motif are invariant in all heavy metal–
transporting P-type ATPases, which led to the proposed
designation “CPx-type ATPase” for this class of proteins
(Solioz and Vulpe 1996). The last cysteine residue of the
motif is replaced in some CPx-type ATPases by serine
or histidine. The functional significance of these changes
is unknown, but they presumably do not adversely affect
the metal-transporting capacity of these proteins. Mu-
tation of both cysteine residues to serine, within the CPC
motif, in the sixth transmembrane segment of ATP7B,
resulted in a protein unable to complement ccc2 mutant
yeast when expressed in single copy or when overex-
pressed from a multicopy vector. Our results comple-
ment those published by Hung et al. (1997), who studied
ATP7B, and Yoshimizu et al. (1998), who studied CUA-
1. In these studies, the CPC motif was replaced with the
amino acids CAC or CPA, respectively, and in both cases
resulted in a mutant protein unable to complement ccc2
mutant yeast. These results, together with ours, are con-
sistent with an essential role for this motif in the function
of ATP7B, as well as for other CPx-type ATPases. Mu-
tations in this motif have not been found in patients
with Wilson disease.
Yeast complementation has been used by other groups
to study the effect of Wilson disease mutations on
ATP7B. Iida et al. (1997) reported that mutations
D1027A and T1029A, within the DKTG motif con-
served in P-type ATPases, and the Wilson disease mu-
tation N1270S are unable to complement ccc2 mutant
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Figure 6 Growth rates of yeast strains in iron-limited medium,
expressed as percent of growth rate of yeast that express normal
ATP7B. Disease-mutation constructs were expressed in the ccc2 mu-
tant background and are designated in the legend by mutation. Black
bars designate ATP7B variants functionally designated as Wilson dis-
ease–causing mutations. White bars indicate normal variants. Gray-
checkered bars indicate possible normal variants or Wilson disease
mutant proteins that are incorrectly localized in hepatocytes. The
black-hatched bar indicates an ATP7B variant functionally designated
as a mutation because of profound temperature sensitivity.
yeast. H1069Q, the most common Wilson disease mu-
tation in northern European populations (Thomas et al.
1995), had a reduced ability to complement in their
assay. This result is in contrast to reports that the
H1069Q mutation and the equivalent mutation in
ATP7A result in proteins unable to complement ccc2
mutant yeast (Hung et al. 1997; Payne and Gitlin 1998).
We have found that the yeast complementation assay is
sensitive to the level of protein expressed, which may
explain this discrepancy. H1069Q likely results in a se-
verely impaired but not inactive ATP7B protein.
Most of the putative Wilson disease mutant proteins
tested in our complementation assay exhibited partial
or normal ability to complement ccc2 mutant yeast,
compared with normal ATP7B proteins. All mutants,
with the exception of T977M and CPC/S, were able to
fully complement ccc2 mutant yeast when overex-
pressed from the multicopy vector, even under condi-
tions of heat stress. These data indicate that these Wilson
disease mutant ATP7B proteins retain at least the partial
ability to transport copper. However, cellular copper ho-
meostasis, mediated by ATP7B, is likely dependent on
both copper-transport activity and localization to the
correct intracellular compartment. ATP7B plays a dual
functional role in the hepatocyte. One role is biosyn-
thetic, involving the delivery of copper to apo-cerulo-
plasmin within the Golgi apparatus (Murata et al. 1995).
The other role of ATP7B is to transport excess copper
out of the cell (Gross et al. 1989; Schilsky et al. 1994).
ATP7B, normally localized in the TGN of hepatocytes
(Hung et al. 1997), trafficks from the TGN to an un-
defined vesicular compartment when cells are exposed
to elevated copper levels, and it recycles back when cop-
per is removed. The observed copper-dependent traf-
ficking may represent a posttranslational inducible
switch from a primarily biosynthetic role in the TGN to
a primarily excretory role that involves membrane ves-
icles, under conditions of copper overload. Wilson dis-
ease missense mutations, such as those analyzed in this
study, may affect copper-dependent trafficking and may
result in a potentially active protein unable to exit the
TGN in response to copper, thereby severely reducing
biliary copper excretion. However, partially or fully ac-
tive mutant ATP7B proteins trapped in the secretory
pathway could transport sufficient copper to constitute
apo-ceruloplasmin during its biosynthesis. This hypoth-
esis may in part explain the phenotype of patients with
hepatic copper accumulation but with normal serum ce-
ruloplasmin levels. Our hypothesis is supported by an
article that was published after submission of this article.
Payne et al. (1998) reported that the H1069Q mutation
results in a mutant ATP7B protein, which, unlike normal
ATP7B, was unable to rescue the copper-sensitive phe-
notype of ATP7A-deficient mottled mouse fibroblasts,
because of temperature-sensitive retention and degra-
dation of ATP7B protein in the endoplasmic reticulum.
The cystic fibrosis transmembrane-conductance regula-
tor (CFTR) has been shown to have a similar defect.
The common DF508 mutation is a temperature-sensitive
mutation, producing a mutant CFTR protein that retains
some chloride-channel activity, but it is not properly
processed and localized to the plasma membrane, which
results in defective cellular chloride conductance (Den-
ning et al. 1992). The intracellular localization of Wilson
disease mutant ATP7B proteins expressed in mammalian
cells must be analyzed to obtain a clear picture of ATP7B
function in both normal and disease states.
The application of yeast complementation to the study
of ATP7B provides an elegant and sensitive method to
assay the putative copper-transporting function of mu-
tant ATP7B proteins, which allows detailed structure/
function analysis. This assay avoids the use of radio-
active copper or silver isotopes to trace copper-trans-
port function in cells or membrane vesicles. As observed
from our growth-rate data, ATP7B is able to replace
Ccc2p with 100% efficiency when expressed from a sin-
gle-copy integrating vector. This demonstrates the valid-
ity of yeast complementation as an assay for ATP7B
function.
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